A free online tool could potentially save some prostate cancer patients more than $9,000 in out-of-pocket drug costs, a Michigan Medicine study finds.

Despite these innovations, a Michigan Medicine study finds that the death rate for pulmonary embolism remains high and unchanged in recent years – more often killing men, Black patients and those from rural areas. The results are published in the Annals of the American Thoracic Society.

Medicaid expansion’s impact on low-income Michigan residents included reduced uninsurance, increased primary and preventive care, and better financial health.

Few children are getting eyes checked at their pediatrician or other regular doctor’s office, and rates vary greatly by insurance status.

RSV vaccines are now available to older adults for the first time; a poll gauges awareness and interest among those over 60.

Mammograms, Pap tests, colonoscopies and lung CT scans have the power to detect cancer early and save lives – a new study tallies up the savings in both years and dollars.

People with chronic pain who take opioids have trouble finding multimodal pain care; insurance and provider education changes are needed, experts say

AI can predict certain forms of esophageal and stomach cancer Michigan Medicine study says.

Michigan Medicine researchers looked into a drug in development to treat prostate cancer called proxalutamide, which works by blocking an enzyme called TMPRSS2 (transmembrane protease, serine 2) that is regulated by androgen receptors, as a potential therapeutic for COVID.